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ABSTRACT
Human serum protein and C-reactive protein levels were determined among HIV patients visiting St Camillus Hospital, 
Uromi, Edo State, Nigeria, between January to March, 2013. Fifty (50) HIV patients (20 males; 30 females) and 50 control 
subjects (24 males; 26 females) were enrolled for this study. The clinical status of the patients was obtained from their 
hospital records. Human serum protein and CRP levels were assayed spectrophotometrically, while CD4 count was done 
using a flow cytometry. Results showed that serum total protein (10.442.32 g/dL), globulin (7.062.37 g/dL) and C-
reactive protein (22.6412.45 mg/L) were significantly higher (p<0.05) in HIV patients than the controls. Albumin (ALB) 
levels (3.380.82  g/dL) and CD4  count of  HIV  patients (419.52338.43 cells/L) was  significantly  lower  (p<0.05)  
than  the  control  subjects. It was concluded that increased serum total protein, globulin, C-reactive protein and low levels 
of albumin and CD4 count, may be a valuable indices in the monitoring and management of HIV infections.
Key words: C-reactive protein, CD4, Total Protein, Albumin, Globulin, HIV
INTRODUCTION
Human immunodeficiency virus infection/Acquired immunodeficiency syndrome (HIV/AIDS) is a disease of the human 
immune system caused by the human immunodeficiency virus (HIV) (Sepkowitz, 2001). HIV is a retrovirus that primarily 
infects components of the human immune system such as CD4+ T cells, macrophages and dendritic cells (Ochie and 
Kolhatkar, 2000; Ogeneh, 2002; Alimonti et al., 2003). It attacks the body's immune system (Siliciano, 2001; Kumar and 
Clark, 2002) resulting in the continuous depletion of CD4 T cells and progressively leads to immunodeficiency, 
opportunistic diseases and finally death (Grossman et al., 2002; Battegay et al., 2004; Mishra et al., 2009). 
Since HIV is characterized by inflammation, C-reactive protein (CRP), is currently the most widely used biomarker of 
inflammation used to monitor HIV infection (Pepys and Hirschfield, 2003; Baker et al., 2010; Funderburg et al., 2010; 
Neuhaus et al., 2010). CRP was so named because it was first identified as a substance in the serum of patients with acute 
inflammation that reacted with the C-polysaccharide of Streptococcus pneumonia (Pepys and Baltz, 1983; Ribeiro, 1997; 
Pepys et al., 2003) and discovered by Tillett and Francis in 1930 (Tillett and Francis, 1930). CRP is synthesized by the 
liver (Pepys et al., 2003), in response to factors released by macrophages and fat cells (adipocytes) (Lau et al., 2005).
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This acute-phase protein present in normal serum, which increases significantly after most forms of tissue injuries, 
bacterial and virus infections, inflammation and malignant neoplasia. During tissue necrosis and inflammation resulting 
from microbial infections, the CRP concentration can rise up to 300mg/L in 12-24 hours (Le Carrer et al., 1995; Vaishnavi, 
1996; Hansson and Lindquist, 1997). Also total protein which measures the level of protein in the blood is increased in 
conditions that cause inflammation while plasma albumin is decreased in inflammatory condition (Fischbach, 2000; Sacher 
et al., 2000).
This study is therefore designed, to determine the levels of human serum protein and C-reactive protein among HIV 
infected subjects Uromi and environs in Edo State, Nigeria. 
MATERIALS AND METHODS
Study design: The present study lasted for three months at St Camillus Hospital, Uromi, Edo State, Nigeria. The subjects 
were 50 HIV Positive patients (20 males and 30 females) (stage 1, stage 2 and stage 3) as described by CDC, (2011) aged 
24 to 49 years, while 50 apparently healthy volunteer HIV Negative subjects (24 males and 26 females) aged 21 to 45 years 
were recruited as the control group.
Ethical approval: Ethical  approval  was  obtained from  the  management  St Camillus  Hospital,  Uromi,  Edo  State,  for 
sample collection.
Inclusion and exclusion criteria: Already diagnosed HIV Positive patients from 24 years and above were recruited for the 
study. HIV Positive patients below 15 and above 50 years were also excluded from this study
Sample collection: Venous blood sample was collected from each subject using a 10mls sterile disposable syringe. This 
was dispensed into a 5mls plain sample containers and EDTA containers labelled with the subject’s name, age and sex. The 
blood sample in the plain containers was spun for 5 minutes at 3000 rpm. The serum was separated from the red cells using 
a dry clean pasteur pipette into a dry clean plain specimen container. The serum was then stored at -20C.
Analytical methods: Total protein was estimated by the Biuret method by Gomall et al. (1949), with kit assay system 
(Cromatest, Spain). Albumin was estimated by the Bromocresol green (BCG) method by Doumas et al. (1971), with kit 
assay system (Cromatest, Spain). Serum globulin was estimated indirectly by subtracting the albumin concentration from 
total protein concentration (Ochie and Kolhatkar, 2000).Serum globulin (g/dl) = Total protein (g/dl) - serum albumin (g/dl). 
C-reactive  protein  estimation  was  carried  out  by  Latex  enhanced  immunoturbidimetry  method; with  kit  assay  
system (Zeigenhagen  and  Drahovshy,  1983).CD4  count  was  done  with Cy- Flow  Counter  which  uses  flurometric  
technique  to detect CD4 cells (Westerman et al., 1994).
Statistical analysis: The results obtained in this study were analyzed statistically.  The mean and Standard deviation values 
were calculated in each case.  Student’s t-test (independent t-test) and One Way Analysis of Variance (ANOVA, LSD) 
statistical method were employed for comparisons using a computer programme (SPSS) for “Windows Release 16.0”.  The 
comparison was done at 95% confidence level, a p-value equal to or less than 0.05 (p ≤ 0.05) were considered statistically 
significant.
RESULTS
Table 1 shows that serum total protein (10.442.32 g/dL), globulin (7.062.37 g/dL) and C-reactive protein (22.6412.45 
mg/L), were significantly higher (p<0.05) in HIV patients than the controls. Albumin (ALB) levels (3.380.82 g/dL) and 
CD4  count of  HIV  patients (419.52338.43 cells/L) was  significantly  lower  (p<0.05)  than  the  control  subjects. 
Table 2 shows the level of Serum CRP, CD4 count, Total protein, Albumin and Globulin in different clinical stages (Stages 
1, 2 and 3) of HIV infected subjects (see also fig. 1 and 2).
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Table 1: Levels of Serum CRP, Total Protein, Albumin, Globulin and CD4 count in HIV infected and control 
subjects 


























Key: n: Number of sample; CD4: Cluster of differentiation; CRP: C-reactive protein; S: Significant; df=49.
Figure I: Graph showing levels of Serum CRP, Total Protein, Albumin, Globulin and CD4 count in HIV infected 
and control subjects
Table 2: The levels of Serum CRP, CD4 count, Total Protein, Albumin and Globulin in different clinical stages of 
HIV infected subjects


























Key: n: Number of sample; CD4: Cluster of differentiation; CRP: C-reactive protein; S: Significant; df=49; Values in a row 
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Figure 2: Graph showing the levels of Serum CRP, CD4 count, Total Protein, Albumin and Globulin in different 
clinical stages of HIV infected subjects .
.
DISCUSSION
The hallmark of HIV disease is the continuous depletion of CD4 T cells, leading to progressive failure of the immune 
system, allowing life-threatening opportunistic infections, cancer and finally death (Saag et al., 1996). Since HIV is 
characterized by infection and inflammation, C-reactive protein (CRP) is the most widely used biomarker of inflammation 
(Pepys and Hirschfield, 2003).
The result of HIV infected subjects when compared with the control values, showed a statistical significant difference in 
the levels of total protein, albumin, globulin, C-reactive protein and CD4 Count (P<0.05). These results obtained in this 
study are in agreement with those reported by Doumas et al., (1971); McGlynn et al., (1995); Fischbach, (2000); Siliciano, 
(2001); Schleicher et al. (2005); Lau et al. (2006);  Wadgera et al. (2012).
The level of serum Total protein, Globulin and CRP in HIV infected subjects were generally higher and low levels of 
Albumin and CD4 were observed when compared with the control subjects. These findings agree with the report of 
Wadgera et al. (2012); McGlynn et al. (1995); Hansson and Lindquist, (1997); Ribeiro (1997); Hattingh et al. (2009). The 
observed high level of total protein and globulin is as a result of acute-phase response that is rapidly harnessed to eliminate 
microbes, control further damage, clear infectious debris, and initiate repair processes and is in line with the reports of 
Yoshida et al. (1999); Hattingh et al. (2009).
The observed high level of CRP is due inflammatory response that is seen HIV patients and is in agreement with the report 
of Vaishnavi (1996); Schleicher et al. (2005); Wadgera et al. (2012). CRP was high because of opportunistic infections. 
Lawn S D et al., (2001) suggested that the serum CRP in HIV infected persons increase only in presence of opportunistic 
infections. The low CD4 count is due to the fact that HIV causes destruction of the immune system largely through 
depletion of CD4 cells which is in agreement with the report of Siliciano (2001); Grossman et al. (2002); Wadgera et al. 
(2012).
The results obtained from clinical staging indicated that as CD4 count declined, the CRP increased from stage 1 to stage 3. 
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3. This is because as CD4 count declined, opportunistic infections set in and the patient developed AIDS at the later stage,
which is in line with the report by Wadgera et al. (2012).
CONCLUSION
It can be concluded from this study that increased serum level of total protein, globulin, C-reactive protein and low levels 
of albumin and CD4 count were observed. These increased serum levels of total protein, globulin, C-reactive protein and 
low levels of albumin and CD4 count in HIV infected subjects, which were not gender or age related, reflected the damage 
to the immune cells as a result of the Human Immunodeficiency Virus (HIV). Therefore, CRP being less expensive and 
take much less time should be incorporated as a routine test in the monitoring and management of HIV infections. 
ACKNOWLEDGEMENT
Our unreserved gratitude goes to all those who contributed to the success of this research and presentation of this 
manuscript. Worthwhile to mention is HRH Igwe C.O Ugwu and Chief Lolo M.N. Ugwu who contributed immensely 
(both morally and financially) to the completion of this research work.
REFERENCES
Alimonti, J.B., Ball, T.B. and Fowke, K.R. (2003): "Mechanisms of CD4+ T lymphocyte cell death in human 
immunodeficiency virus infection and AIDS". Journal of General Virology; 84 (7): 1649–1661.
Baker, J., Ayenew, W. and Quick, H. (2010): High-density lipoprotein particles and markers of inflammation and 
thrombotic activity in patients with untreated HIV infection. Journal of Infectious Diseases; 201:285–292.
Battegay, M., Hans, H., Hirsch, G. and Sendi, P. (2004):  Immune Reconstitution in HIV Infected Patients. Clinical 
Infectious Diseases; 38:1159–1166.
CDC, (2011): "HIV surveillance—United States, 1981–2008". MMWR. Morbidity and mortality weekly report; 60 (21): 
689–693.
Doumas, B.T., Wastson, W.A. and Biggs, H.G. (1971): The human version is human serum albumin. Clinical Chim. Acta; 
3: 87.
Fischbach, F. (2000): "Diagnostic Testing." In A Manual of Laboratory and Diagnostic Tests, 6th ed. Philadelphia: 
Lippincott Wiiliams and Wilkins. Pp. 1-25.
Funderburg, N.T, Mayne, E. and Sieg, S.F. (2010): Increased tissue factor expression on circulating monocytes in chronic 
HIV infection: relationship to in vivo coagulation and immune activation. Blood; 115:161–167.
Gomall, A.G., Bardawill, C.S. and David, M.M. (1949): Determination of Serum proteins by means of the biuret reaction. 
Journal of biological chemistry; (177):751.
Grossman, Z., Schellersheim, M.M., Ana, E. and William e. Paul (2002): CD4+ T-cell depletion in HIV infection: Are we 
closer to understanding the cause? Nature Medicine; 8 (4):319-323.
Hansson, L.O. and Lindquist, L. (1997): C-reactive protein: Its role in the diagnosis and follow-up of infectious diseases.  
Current Opinion in infectious Diseases; 10: 196 - 201.
Hattingh, Z., Walsh, C., Veldman, F.J. and Bester, C.J. (2009): The metabolic profiles of HIV-infected and non-infected 
women in Mangaung, South Africa. South African Journal of Clinical Nutrition; 22(1):23-28.
Lau, D.C., Dhillon, B., Yan, H., Szmitko, P.E. and Verma, S. (2005). "Adipokines: molecular links between obesity and 
atheroslcerosis". American Journal of Physiology. Heart and Circulatory Physiology; 288 (5): H2031–41.
79
Ugwu et al., IJBAIR, 2016, 5(3): 74 - 80
Lau, B., Sharrett, A.R., Kingsley, L.A., Post, W., Palella, F.J., Visscher, B. and Gange, S.J. (2006): C-reactive protein is a 
marker for human immunodeficiency virus disease progression. Archives of Internal Medicine; 166(1):64-70.
Lawn, S.D., Wiktor, S., Coulibaly, D., Ackah, A.N. and Lal, R.B. (2001): Serum C-reactive protein and detection of 
tuberculosis in persons co-infected with the human immunodeficiency virus. Transactions of the Royal Society of Tropical 
Medicine and Hygiene; 95(1):41-42.
Le Carrer, D., Giraud, .F, Siramy, M. and Bataille, R. (1995): Proteine C-reactive: Re’evaluation des valeurs normales par 
une unc technique nephelemetrique sensibilisee. Feuillets de Biologie; 34: 39-42.
McGlynn, K., Rosvold, E., Lustbade, E., Hu, Y., Clapper, M. and Zhou, T. (1995): Susceptibility to hepatocellular 
carcinoma is associated with genetic variation in the protein denaturalization of aflation. Proceedings of the National 
Academy of Sciences.92: 2384 – 2387.
Mishra, S., Dwivedi, S.P. and Singh, R.B. (2009): Immune Response and Possible Causes of CD4+T-cell Depletion in 
Human Immunodeficiency Virus (HIV)- 1 Infection. The Open Nutraceuticals Journal.2:46-51.
Neuhaus, J., and Jacobs, Baker, J.V. (2010): Markers of inflammation, coagulation, and renal function are elevated in 
adults with HIV infection. Journal of Infectious Diseases.201:1788–1795.
Ochie, J. and Kolhatkar, A. (2000): Medical Laboratory Science, theory and practice. Tata McGraw-Hill Company limited, 
New Delli, New York. P.159.
Ogeneh, B.O. (2002): Introductory Medical Microbiology.1st ed., Kinsmann publishers, Enugu. P.82.
Pepys, M.B. and Baltz, M.L. (1983): Acute phase proteins with special reference to C-reactive protein and related proteins 
(pentaxins) and serum amyloid A protein. Advances in Immunology.34:141–212.
Pepys, M.B. and Hirschfield, G.M. (2003): C-reactive protein: a critical update. Journal of Clinical 
Investigation.111:1805-1812.
Ribeiro, M.A. (1997):  Levels of C-reactive protein in serum samples from healthy children and adults in So Paulo, Brazil. 
Brazilian Journal of Medicine and Biological Research.30 (9).
Saag, M.S., Holodniy, M. and Kuritzkes, D.R. (1996): HIV viral load markers in clinical practice. Nature Medicine.2:625–
629.
Schleicher, G.K., Herbert, V., Brink, A., Martin, S., Maraj, R., Galpin, J.S. and Feldman, C. (2005): Procalcitonin and C-
reactive protein levels in HIV-positive subjects with tuberculosis and pneumonia. European Respiratory Journal.25: 688–
692.
Sepkowitz, K.A. (2001): "AIDS—the first 20 years". New England Journal of Medicine. 344 (23):1764– 1772.
Siliciano, R.F. and Hopkins, J. (2001): Acquired Immune Deficiency Syndrome (AIDS) University, Baltimore, Maryland, 
USA.Pp.1-12
Tillett, W.S. and Francis, T. (1930): "Serological reactions in pneumonia with a nonprotein somatic fraction of 
pneumococcus". Journal of Experimental Medicine.52 (4): 561–571. 
Vaishnavi, C. (1996):  C-reactive protein in bacterial infections. Immunology and Infectious Diseases; 6:139-144. 
Wadgera, N.Y., Yadhav, M.L. and Nagaraja, B.S. (2012): c-reactive protein as an early marker of opportunistic infections 
in HIV. International Journal of Pharmacy and Biological Sciences 3(4): (B) 1194 - 1203
80
Ugwu et al., IJBAIR, 2016, 5(3): 74 - 80
Westerman, L.E., Kohatsu, L., Ortiz, A., McClain, B. and Kaplan et al., (1994): A Quality Management Systems 
Approach for CD4 Testing in Resource-Poor Settings. American Journal of Clinical Pathology.134:556-567
Yoshida, S.H., Keen, C.L., Ansari, A.A. and Gershwin, M.E.(1999): Nutrition and the immune system. In: Shils ME, 
Olson JA, Shike M, Ross AC, eds. Modern nutrition in health and disease. 9th ed. Baltimore, MD: Williams and Wilkins, 
Menlo Park, C.A: Health Pub; 725–750.
Zeigenhagen, G. and Drahovshy, D. (1983): Klinishe Bedeutung des C-reactiven protein. Med Klin.78:45-50.
AUTHORS’ CONTRIBUTIONS
All authors (Ugwu, M.C., Okogun, G.R.A., Okoye, C.F., Ekebor, K.L., Nwafia, C.J., Nnona, A.E., Obodo, B.N.) 
contributed to the completion of this research work and were actively involved in the presentation of this manuscript.
